AI assistant
ANGIODYNAMICS INC — Director's Dealing 2020
Feb 7, 2020
32939_dirs_2020-02-07_6708c375-1a6a-439f-b06c-f84abef781dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-02-03
Reporting Person: Trowbridge Stephen A (EVP, General Counsel and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-03 | Common Stock | A | 5376 | — | Acquired | 45499 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-03 | Non-Qualified Stock Option (right to buy) | $13.80 | A | 18204 | Acquired | 2030-02-03 | Common Stock (18204) | Direct |
Footnotes
F1: This acquisition of 5,376 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 5,376 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on February 3, 2021, such that 25% of the restricted stock units will vest on each of February 3, 2021, 2022, 2023 and 2024.
F2: These stock options vest in four equal annual installments beginning on February 3, 2021, such that 25% of the options will vest on each of February 3, 2021, 2022, 2023 and 2024.